SEC Form 4 · accession 0001567619-18-002003
ADURO BIOTECH, INC. · ADRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ross Haghighat
Director
Period of report
Aug 29, 2018
Accepted (ET)
Aug 31, 2018 · 7:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001435049
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 29, 2018 | J | 50,297 | — | D | 31,583 | D | |
| Common StockF1,F2 | Aug 29, 2018 | J | 50,297 | — | A | 107,005 | I | See Footnote |
| Common StockF3 | holding | — | — | — | 208,807 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person contributed the shares to Triton Systems, Inc. for no consideration.
- F2The shares are directly held by Triton Systems, Inc. ("Triton"). The reporting person may be deemed to beneficially own the securities held by Triton. The Reporting Person is president, CEO, a director and a shareholder of Triton. The Reporting Person disclaims beneficial ownership of such securities except to the extent of any pecuniary interest therein.
- F3The shares are directly held by Triton Holdings, LLC ("Holdings"). Triton is the managing member of Holdings. The Reporting Person is president, CEO, a director and a shareholder of Triton. The Reporting Person disclaims beneficial ownership of such securities except to the extent of any pecuniary interest therein.